Spread of VIM-2 metallo-beta-lactamase in Pseudomonas aeruginosa and Acinetobacter baumannii clinical isolates from Iaşi, Romania
By: Ana Irina Mereuţă, Aida Corina Bădescu, Olivia Simona Dorneanu, Luminiţa Smaranda Iancu and Cristina Gabriela Tuchiluş
Open Access
|Dec 2013References
- 1. Gupta V. Metallo beta lactamases inandspecies. Expert Opin Investig Drugs. 2008 Feb; 17(2):131-43.
- 2. Walsh TR, Toleman MA, Poirel L, Nordmann P. Metallo- β-lactamases: the quiet before the storm? Clin Microbiol Rev. 2005 Apr; 18:306-325.
- 3. Walsh F, Amyes SG. Carbapenem resistance in clinical isolates of. J Chemother. 2007 Aug; 19:376-381.
- 4. Cornaglia G, Giamarellou H, Rossolini GM. Metallo- β-lactamases: a last frontier for β-lactams? Lancet Infect Dis. 2011 May; 11(5):381-393.
- 5. Giakkoupi P, Petrikkos G, Tzouvelekis L, Tsonas S, Legakis N, Vatopoulos A. Spread of integron-associated VIM-type metallo-β-lactamase genes among imipenemnonsusceptiblestrains in Greek hospitals. J Clin Microbiol. 2003 Feb; 41(2): 822-825.
- 6. Rossolini GM, Luzzaro F, Migliavacca R, Mugnaioli C, Pini B, De Luca F, et al. First countrywide survey of acquired metallo-β-lactamases in gram-negative pathogens in Italy. Antimicrob Agents Chemother. 2008 Nov; 52(11):4023-4029.
- 7. Hocquet D, Plésiat P, Dehecq B, Mariotte P, Talon D, Bertrand X. Nationwide investigation of extended-spectrum β-lactamases, metallo-β-lactamases, and extended- spectrum oxacillinases produced by ceftazidime- resistantstrains in France. Antimicrob Agents Chemother. 2010 Aug; 54(8):3512-3515.
- 8. Valenza G, Joseph B, Elias J, Heike C, Oesterlein A, Engelhardt K, et al. First survey of metallo-beta-lactamases in clinical isolates ofin a German university hospital. Antimicrob Agents Chemother. 2010 Aug; 54(8): 3493-3497.
- 9. www.lahey.org/Studies
- 10. Poirel L, Naas T, Nicolas D, Collet L, Bellais S, Cavallo JD, et al. Characterization of VIM-2, a carbapenem- hydrolyzing metallo-β-lactamase and its plasmid- and integron-borne gene from aclinical isolate in France. Antimicrob Agents Chemother. 2000 Apr; 44(4):891-897.
- 11. Zhao WH, Hu ZQ. Epidemiology and genetics of VIM-type metallo-β-lactamases in Gram-negative bacilli. Future Microbiol. 2011 Mar; 6(3):317-333.
- 12. Elias J, Schoen C, Heinze G, Valenza G, Gerharz E, Riedmiller H, et al. Nosocomial outbreak of VIM-2 metallo- β-lactamase-producingassociated with retrograde urography. Clin Microbiol Infect. 2010 Sept; 16(9):1494-1500.
- 13. Van der Bij A, Van Mansfeld R, Peirano G, Goessens W, Severin J, Pitout J, et al. First outbreak of VIM-2 metallo- β-lactamase-producingin The Netherlands: microbiology, epidemiology and clinical outcomes. Int J Antimicrob Agents. 2011 Jun; 37(6):513-518.
- 14. Viedma E, Juan C, Villa J, Barrado L, Orellana MA, Sanz F, et al. VIM-2-producing multidrug-resistantST175 clone, Spain. Emerg Infect Dis. 2012 Aug; 18(8): 1235-1241.
- 15. Cernat R, Balotescu C, Lazar V, Banu O, Ivanescu D, Bucur M. Genetic characterisation of highly prevalent MBLs and OXA carbapenemases in multidrug-resistantstrains in a Romanian hospital. Clin Microbiol Infect. 2007 Apr; 13(s1):O436.
- 16. Mereuta AI, Docquier JD, Rossolini GM, Buiuc D. Detection of metallo-beta-lactamases in gram-negative bacilli isolated in hospitals from Romania-research fellowship report. Bacteriol Virusol Parazitol Epidemiol. 2007 Jan-Jun; 52:45-49.
- 17. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. 22th informational supplement. 2012. CLSI M100-S22, Wayne, PA.
- 18. Migliavacca R, Docquier JD, Mugnaioli C, Amicosante G, Daturi R, Lee KW, et al. Simple microdilution test for detection of metallo-β-lactamase production in. J Clin Microbiol. 2002 Nov; 40(11):4388-4390.
- 19. Docquier JD, Riccio ML, Mugnaioli C, Luzzaro F, Endimiani A, Toniolo A, et al. IMP-12, a new plasmid encoded metallo-β-lactamase from aclinical isolate. Antimicrob Agents Chemother. 2003 May; 47(5):1522-1528.
- 20. Nordmann P, Poirel L, Carrër A, Toleman MA, Walsh TR. How to detect NDM-1 producers. J Clin Microbiol. 2011 Feb; 49(2): 718-721.
- 21. Campbell M, Mahenthiralingam E, Speert DP. Evaluation of Random Amplified Polymorphic DNA Typing of. J Clin Microbiol. 2000 Dec; 38 (12):4614-4615.
- 22. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug- resistant and pandrug-resistant: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012 Mar; 18(3): 268-281.
- 23. Zhao WH, Chen G, Ito R, Hu ZQ. Relevance of resistance levels to carbapenems and integron-borneIMP-1,IMP-7,IMP-10 andVIM-2 in clinical isolates of. J Med Microbiol. 2009 Aug; 58(8):1080-1085.
- 24. Franco MRG, Caiaffa-Filho HH, Burattini MN, Rossi F. Metallo-beta-lactamases among imipenem-resistantin a Brazilian university hospital. Clinics. 2010; 65(9):825-829.
- 25. Jovcic B, Vasiljevcic Z, Djukic S, Topisirovic L, Kojic M. Emergence of VIM-2 metallo-beta-lactamase-producingisolates in a paediatric hospital in Serbia. J Med Microbiol. 2011 Jun; 60(6): 868-869.
- 26. Ratkai C, Quinteira S, Grosso F, Monteiro N, Nagy E, Peixe L. Controlling for false positives: interpreting MBL Etest and MBL combined disc test for the detection of metallo-β-lactamases. J Antimicrob Chemother. 2009 Sept; 64(3):657-658.
- 27. Samuelsen O, Buarø L, Giske CG, Simonsen GS, Aasnaes B, Sundsfjord A. Evaluation of phenotypic tests for the detection of metallo-β-lactamase-producingin a low prevalence country. J Antimicrob Chemother. 2008 Apr; 61(4):827-830.
- 28. Khosravi Y, Tay ST, Vadivelu J. Analysis of integrons and associated gene cassettes of metallo-β-lactamase- positivein Malaysia. J Med Microbiol. 2011 Jul; 60 (7):988-994.
- 29. Hammami S, Gautier V, Ghozzi R, Da Costa A, Ben- Redjeb S, Arlet G. Diversity in VIM-2-encoding class 1 integrons and occasionalSHV2a carriage in isolates of a persistent, multidrug-resistantclone from Tunis. Clin Microbiol Infect. 2010 Feb; 16(2):189-193.
- 30. Straut M, Dinu S, Cretoiu S, Lixandru B, Surdeanu M. Molecular characterization of genetic structures surroundingVIM-2 gene identified inclinical isolates from Romania. Clin Microbiol Infect. 2010 Apr; 16(S2):197.
- 31. Toleman MA, Vinodh H, Sekar U, Kamat V, Walsh TR.VIM-2 - harbouring integrons isolated in India, Russia and United States arise from an ancestral class 1 integron predating the formation of 3' conserved sequence. Antimicrob Agents Chemother. 2007 Jul; 51(7): 2336-2638.
DOI: https://doi.org/10.2478/rrlm-2013-0035 | Journal eISSN: 2284-5623 | Journal ISSN: 1841-6624 (formerly 2284-5623)
Language: English, Romanian
Page range: 423 - 430
Published on: Dec 31, 2013
Published by: Romanian Association of Laboratory Medicine
In partnership with: Paradigm Publishing Services
Related subjects:
© 2013 Ana Irina Mereuţă, Aida Corina Bădescu, Olivia Simona Dorneanu, Luminiţa Smaranda Iancu, Cristina Gabriela Tuchiluş, published by Romanian Association of Laboratory Medicine
This work is licensed under the Creative Commons License.